Show source-provided references
1. Marx, R.E. (2007). Oral and Intravenous Bisphosphonate-Induced Osteonecrosis of the Jaws. History, Etiology, Prevention, and Treatment, Quintessence Publishing Co., Inc.
2. American Dental Association Council on Scientific Affairs (2006). Dental management of patients receiving oral bisphosphonatetherapy: Expert panel recommendations. J. Am. Dent. Assoc., 137, 1144–1150.
10.14219/jada.archive.2006.0355 ↗5. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw-2014 update
10.1016/j.joms.2014.04.031 ↗8. The role of dental care providers in the management of patients prescribed bisphosphonates: Brief clinical guidance
10. Campisi, G., Mauceri, R., Bertoldo, F., Bettini, G., Biasotto, M., Colella, G., Consolo, U., Di Fede, O., Favia, G., and Fusco, V. (2020). Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020. Int. J. Environ. Res. Public Health, 17.
10.3390/ijerph17165998 ↗11. Osteonecrosis of Jaw Related to Bisphosphonates and Other Drugs—Prevention, Diagnosis, Pharmacovigilance, Treatment: A 2021 Web Event
10.3390/oral2020014 ↗12. De Cicco, D., Boschetti, C.E., Santagata, M., Colella, G., Staglianò, S., Gaggl, A., Bottini, G.B., Vitagliano, R., and D’amato, S. (2023). Medication-Related Osteonecrosis of the Jaws: A Comparison of SICMF–SIPMO and AAOMS Guidelines. Diagnostics, 13.
10.3390/diagnostics13132137 ↗13. Bovari-Biri, J., Miskei, J.A., Kover, Z., Steinerbrunner-Nagy, A., Kardos, K., Maroti, P., and Pongracz, J.E. (2025). Advancements in Bone Replacement Techniques–Potential Uses After Maxillary and Mandibular Resections Due to Medication-Related Osteonecrosis of the Jaw (MRONJ). Cells, 14.
10.3390/cells14020145 ↗14. Laputková, G., Talian, I., and Schwartzová, V. (2023). Medication-Related Osteonecrosis of the Jaw: A Systematic Review and a Bioinformatic Analysis. Int. J. Mol. Sci., 24.
10.3390/ijms242316745 ↗15. Caggiano, M., Di Spirito, F., Acerra, A., Galdi, M., and Sisalli, L. (2023). Multiple-Drugs-Related Osteonecrosis of the Jaw in a Patient Affected by Multiple Myeloma: A Case Report. Dent. J., 11.
10.3390/dj11040104 ↗18. Medication-related osteonecrosis of the jaw: Definition and best practice for prevention, diagnosis, and treatment
10.1016/j.oooo.2018.09.008 ↗19. A review of bisphosphonate-associated osteonecrosis of the jaws and its management
20. Guidelines for the diagnosis of bisphosphonate-related osteonecrosis of the jaw (BRONJ)
23. Craniofacial manifestations of systemic disorders: CT and MR imaging findings and imaging approach
10.1148/rg.2018170145 ↗24. Ko, Y.Y., Yang, W.-F., and Leung, Y.Y. (2024). The Role of Cone Beam Computed Tomography (CBCT) in the Diagnosis and Clinical Management of Medication-Related Osteonecrosis of the Jaw (MRONJ). Diagnostics, 14.
10.3390/diagnostics14161700 ↗25. Berg, B.-I., Mueller, A.A., Augello, M., Berg, S., and Jaquiéry, C. (2016). Imaging in Patients with Bisphosphonate-Associated Osteonecrosis of the Jaws (MRONJ). Dent. J., 4.
10.3390/dj4030029 ↗26. Kojima, Y., Soutome, S., Otsuru, M., Hayashida, S., Sakamoto, Y., Sawada, S., and Umeda, M. (2022). Factors Exacerbating Clinical Symptoms and CT Findings in Patients with Medication-Related Osteonecrosis of the Jaw Receiving Conservative Therapy: A Multicenter Retrospective Study of 53 Cases. Int. J. Environ. Res. Public Health, 19.
10.3390/ijerph19137854 ↗27. Ibrahim, N., Apandi, N.I.M., Shuhardi, S.A., and Ramli, R. (2022). Actinomyces sp. Presence in the Bone Specimens of Patients with Osteonecrosis of the Jaw: The Histopathological Analysis and Clinical Implication. Antibiotics, 11.
10.3390/antibiotics11081067 ↗28. Ciobanu, G.A., Mogoantă, L., Camen, A., Ionescu, M., Vlad, D., Staicu, I.E., Munteanu, C.M., Gheorghiță, M.I., Mercuț, R., and Sin, E.C. (2023). Clinical and Histopathological Aspects of MRONJ in Cancer Patients. J. Clin. Med., 12.
10.3390/jcm12103383 ↗29. Chmielewski, M., Pilloni, A., and Adamska, P. (2024). Application of Advanced Platelet-Rich Fibrin in Oral and Maxillo-Facial Surgery: A Systematic Review. J. Funct. Biomater., 15.
10.3390/jfb15120377 ↗30. Adamska, P., Kaczoruk-Wieremczuk, M., Pylińska-Dąbrowska, D., Stasiak, M., Bartmański, M., Zedler, A., and Studniarek, M. (2024). Treatment of Oroantral Communication and Fistulas with the Use of Blood-Derived Platelet-Rich Preparations Rich in Growth Factors: A Systematic Review. Int. J. Mol. Sci., 25.
10.3390/ijms252111507 ↗31. Adamska, P., Pylińska-Dąbrowska, D., Stasiak, M., Kaczoruk-Wieremczuk, M., Kozłowska, E., Zedler, A., and Studniarek, M. (2024). Treatment of Odontogenic Maxillary Sinusitis with the Use of Growth Factors in Advanced Platelet-Rich Fibrin for Immediate Closure of Oro-Antral Communication: A Case Report. Int. J. Mol. Sci., 25.
10.3390/ijms25084339 ↗32. Chmielewski, M., Pilloni, A., and Adamska, P. (2025). Advanced Platelet-Rich Fibrin Plus (A-PRF+) as an Additive to Hard Tissue Managing Protocols in Oral Surgery: A Systematic Review. J. Funct. Biomater., 16.
10.3390/jfb16040145 ↗33. Adamska, P., Pylińska-Dąbrowska, D., Stasiak, M., Sobczak-Zagalska, H., Jusyk, A., Zedler, A., and Studniarek, M. (2024). Tooth Autotransplantation, Autogenous Dentin Graft, and Growth Factors Application: A Method for Preserving the Alveolar Ridge in Cases of Severe Infraocclusion—A Case Report and Literature Review. J. Clin. Med., 13.
10.3390/jcm13133902 ↗34. Medication-related osteonecrosis of the jaw: Is autologous platelet concentrate application effective for prevention and treatment? A systematic review
10.1016/j.jcms.2016.05.004 ↗35. Frutuoso, F., Freitas, F., Vilares, M., Francisco, H., Marques, D., Caramês, J., and Moreira, A. (2024). Medication-Related Osteonecrosis of the Jaw: A Systematic Review of Case Reports and Case Series. Diseases, 12.
10.3390/diseases12090205 ↗36. Kaczmarczyk, T., Babiuch, K., Bołtacz-Rzepkowska, E., Dominiak, M., Konopka, T., Lipski, M., Olczak-Kowalczyk, D., Szeląg, A., Szuta, M., and Hryniewicz, W. (2019). Rekomendacje Grupy Roboczej Polskiego Towarzystwa Stomatologicznego i Narodowego Programu Ochrony Antybiotyków w Zakresie Stosowania Antybiotyków w Stomatologii, Narodowy Instytut Leków.
39. Nica, D.F., Riviș, M., Roi, C.I., Todea, C.D., Duma, V.-F., and Sinescu, C. (2021). Complementarity of Photo-Biomodulation, Surgical Treatment, and Antibiotherapy for Medication-Related Osteonecrosis of the Jaws (MRONJ). Medicina, 57.
10.3390/medicina57020145 ↗40. Efficacy and safety of medical ozone (O(3)) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: Preliminary results of a phase I-II study
10.1016/j.oraloncology.2011.01.002 ↗41. Kwon, Y.-D., and Kim, D.-Y. (2016). Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ). Dent. J., 4.
10.3390/dj4040041 ↗42. Short-term teriparatide and recombinant human bone morphogenetic protein-2 for regenerative approach to medication-related osteonecrosis of the jaw: A preliminary study
10.1002/jbmr.3237 ↗43. Colapinto, G., Goker, F., Nocini, R., Albanese, M., Nocini, P.F., Sembronio, S., Argenta, F., Robiony, M., and Del Fabbro, M. (2023). Outcomes of a Pharmacological Protocol with Pentoxifylline and Tocopherol for the Management of Medication-Related Osteonecrosis of the Jaws (MRONJ): A Randomized Study on 202 Osteoporosis Patients. J. Clin. Med., 12.
10.3390/jcm12144662 ↗44. Michalak, F., Dominiak, M., Kiryk, J., Popecki, P., Kubicki, D., Matys, J., and Grzech-Leśniak, K. (2025). The Influence of Vitamin D Levels and Supplementation on the Treatment of Patients Affected by MRONJ. Appl. Sci., 15.
10.3390/app15020670 ↗45. Pardo-Zamora, G., Martínez, Y., Moreno, J.A., and Ortiz-Ruíz, A.J. (2021). Treatment of Stage 2 Medication-Induced Osteonecrosis of the Jaw: A Case Series. Int. J. Environ. Res. Public Health, 18.
10.3390/ijerph18031018 ↗46. Autologous platelet-rich fibrin injections in the management of facial cutaneous sinus tracts secondary to medication-related osteonecrosis of the jaw
10.1111/dth.13334 ↗48. Case reports of medication-related osteonecrosis of the jaw (MRONJ) treated with uncultured stromal vascular fraction and L-PRF
10.1016/j.jormas.2020.05.024 ↗49. Usefulness of advanced-platelet rich fibrin (A-PRF) and injectable-platelet rich fibrin (i-PRF) in the management of a massive medication-related osteonecrosis of the jaw (MRONJ): A 5-years follow-up case report
10.4103/ijdr.IJDR_689_19 ↗50. Platelet-rich fibrin may reduce the risk of delayed recovery in tooth-extracted patients undergoing oral bisphosphonate therapy: A trial study
10.1007/s00784-016-2004-z ↗51. Miranda, M., Gianfreda, F., Raffone, C., Antonacci, D., Pistilli, V., and Bollero, P. (2021). The Role of Platelet-Rich Fibrin (PRF) in the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ). Biomed. Res. Int., 2021.
10.1155/2021/4948139 ↗52. The role of leukocyte and platelet-rich fibrin in the prevention of medication-related osteonecrosis of the jaw, in patients requiring dental extractions: An observational study
10.1007/s10006-023-01204-z ↗53. Prevention and management of drug-induced osteonecrosis of the jaws using platelet-rich fibrin: A clinical feasibility study
10.1002/cre2.775 ↗54. Efficacy of fibrin-rich platelets and leukocytes (L-PRF) in tissue repair in surgical oral procedures in patients using zoledronic acid-case-control study
10.1007/s10006-022-01094-7 ↗55. Prevention of medication related osteonecrosis of the jaw after dentoalveolar surgery: An institution’s experience
57. Can platelet-rich fibrin improve healing after surgical treatment of medication-related osteonecrosis of the jaw? A pilot study
10.1016/j.oooo.2018.06.007 ↗58. Platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: A clinical and histopathological evaluation
59. The use of platelet-rich fibrin in the surgical treatment of medication-related osteonecrosis of the jaw: 40 patients prospective study
10.5507/bp.2020.023 ↗60. Özalp, Ö., Yıldırımyan, N., Öztürk, C., Kocabalkan, B., Şimşek Kaya, G., Sindel, A., and Altay, M.A. (2021). Promising results of surgical management of advanced medication related osteonecrosis of the jaws using adjunctive leukocyte and platelet rich fibrin. BMC Oral Health, 21.
10.1186/s12903-021-01965-7 ↗61. Does the Addition of Bone Morphogenetic Protein 2 to Platelet-Rich Fibrin Improve Healing After Treatment for Medication-Related Osteonecrosis of the Jaw?
10.1016/j.joms.2016.12.005 ↗62. The adjunctive use of Leukocyte-Platelet Rich Fibrin (L-PRF) in the management of Medication Related Osteonecrosis of the Jaw (MRONJ): A retrospective observational study
10.1007/s10006-024-01291-6 ↗63. Use of Leukocyte-rich and Platelet-rich Fibrin (L-PRF) Adjunct to Surgical Debridement in the Treatment of Stage 2 and 3 Medication-Related Osteonecrosis of the Jaw
10.1097/SCS.0000000000009161 ↗64. Tenore, G., Zimbalatti, A., Rocchetti, F., Graniero, F., Gaglioti, D., Mohsen, A., Caputo, M., Lollobrigida, M., Lamazza, L., and De Biase, A. (2020). Management of Medication-Related Osteonecrosis of the Jaw (MRONJ) Using Leukocyte- and Platelet-Rich Fibrin (L-PRF) and Photobiomodulation: A Retrospective Study. J. Clin. Med., 9.
10.3390/jcm9113505 ↗65. Jamalpour, M.R., Shahabi, S., Baghestani, M., Shokri, A., Jamshidi, S., and Khazaei, S. (2022). Complementarity of surgical therapy, photobiomodulation, A-PRF and L-PRF for management of medication-related osteonecrosis of the jaw (MRONJ): An animal study. BMC Oral Health, 22.
10.1186/s12903-022-02275-2 ↗66. The use of advanced-platelet rich fibrin (A-PRF) in the management of medication-related osteonecrosis of the jaw (MRONJ): A case report
10.1002/ccr3.8259 ↗67. Roman, R.C., Moldovan, M.A., Pop, L.S., Megieșan, S., and Faur, C.I. (2024). Platelet-Rich Fibrin Treatment Evaluation in Patients with Medication-Related Osteonecrosis of the Jaw and Osteoradionecrosis. J. Clin. Med., 13.
10.3390/jcm13123473 ↗68. Blatt, S., Krüger, M., Kämmerer, P.W., Thiem, D.G.E., Matheis, P., Eisenbeiß, A.-K., Wiltfang, J., Al-Nawas, B., and Naujokat, H. (2022). Non-Interventional Prospective Observational Study of Platelet Rich Fibrin as a Therapy Adjunctive in Patients with Medication-Related Osteonecrosis of the Jaw. J. Clin. Med., 11.
10.3390/jcm11030682 ↗